Cargando…
Opioid-Induced Constipation in Real-World Practice: A Physician Survey, 1 Year Later
INTRODUCTION: Opioid-induced constipation (OIC) is the most common adverse effect of opioid therapy, but it is underdiagnosed and undertreated. Last year, a survey among Italian healthcare providers revealed important differences in the clinical management of OIC across physician specialties, the ne...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098716/ https://www.ncbi.nlm.nih.gov/pubmed/35122615 http://dx.doi.org/10.1007/s40122-022-00354-4 |
_version_ | 1784706440770879488 |
---|---|
author | Alvaro, Domenico Coluzzi, Flaminia Gianni, Walter Lugoboni, Fabio Marinangeli, Franco Massazza, Giuseppe Pinto, Carmine Varrassi, Giustino |
author_facet | Alvaro, Domenico Coluzzi, Flaminia Gianni, Walter Lugoboni, Fabio Marinangeli, Franco Massazza, Giuseppe Pinto, Carmine Varrassi, Giustino |
author_sort | Alvaro, Domenico |
collection | PubMed |
description | INTRODUCTION: Opioid-induced constipation (OIC) is the most common adverse effect of opioid therapy, but it is underdiagnosed and undertreated. Last year, a survey among Italian healthcare providers revealed important differences in the clinical management of OIC across physician specialties, the need of standardization of diagnosis and treatment, and the urgency of further education. Herein, we submitted an updated version of the survey to the same cohort of experts to evaluate potential progress. METHODS: The online survey included 15 questions about OIC. Responses were analyzed descriptively and aggregated by physician specialty. RESULTS: A total of 190 physicians completed the survey. Most respondents (65%) did not feel adequately educated about OIC despite general consensus regarding interest in the topic and acknowledgement of OIC impact on patients’ QoL and adherence to opioid therapy. Overall, 55–77% of physicians regularly evaluated intestinal function or OIC symptoms in patients receiving opioid therapy, with one-third of respondents implementing it in the past year. Even though the most common method for assessment was still patient diary, the use of specific scales underwent a small but significant increase compared to the previous year, with major implementation in the use of Rome IV criteria. As regards first-line treatment, most respondents (49%) preferred macrogol prophylaxis followed by macrogol plus another laxative. For second-line treatment, we revealed a growth in the prescription of peripherally acting mu-opioid receptor antagonists (PAMORAs), with 46% of all the respondents having increased their use during the past year. CONCLUSIONS: Despite some limitations, our study demonstrated a slow but important step closer to standardization of diagnosis and treatment of OIC. Further educational and training efforts should be put in place to favor best evidence-based clinical practice. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40122-022-00354-4. |
format | Online Article Text |
id | pubmed-9098716 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-90987162022-05-14 Opioid-Induced Constipation in Real-World Practice: A Physician Survey, 1 Year Later Alvaro, Domenico Coluzzi, Flaminia Gianni, Walter Lugoboni, Fabio Marinangeli, Franco Massazza, Giuseppe Pinto, Carmine Varrassi, Giustino Pain Ther Original Research INTRODUCTION: Opioid-induced constipation (OIC) is the most common adverse effect of opioid therapy, but it is underdiagnosed and undertreated. Last year, a survey among Italian healthcare providers revealed important differences in the clinical management of OIC across physician specialties, the need of standardization of diagnosis and treatment, and the urgency of further education. Herein, we submitted an updated version of the survey to the same cohort of experts to evaluate potential progress. METHODS: The online survey included 15 questions about OIC. Responses were analyzed descriptively and aggregated by physician specialty. RESULTS: A total of 190 physicians completed the survey. Most respondents (65%) did not feel adequately educated about OIC despite general consensus regarding interest in the topic and acknowledgement of OIC impact on patients’ QoL and adherence to opioid therapy. Overall, 55–77% of physicians regularly evaluated intestinal function or OIC symptoms in patients receiving opioid therapy, with one-third of respondents implementing it in the past year. Even though the most common method for assessment was still patient diary, the use of specific scales underwent a small but significant increase compared to the previous year, with major implementation in the use of Rome IV criteria. As regards first-line treatment, most respondents (49%) preferred macrogol prophylaxis followed by macrogol plus another laxative. For second-line treatment, we revealed a growth in the prescription of peripherally acting mu-opioid receptor antagonists (PAMORAs), with 46% of all the respondents having increased their use during the past year. CONCLUSIONS: Despite some limitations, our study demonstrated a slow but important step closer to standardization of diagnosis and treatment of OIC. Further educational and training efforts should be put in place to favor best evidence-based clinical practice. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40122-022-00354-4. Springer Healthcare 2022-02-05 2022-06 /pmc/articles/PMC9098716/ /pubmed/35122615 http://dx.doi.org/10.1007/s40122-022-00354-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Original Research Alvaro, Domenico Coluzzi, Flaminia Gianni, Walter Lugoboni, Fabio Marinangeli, Franco Massazza, Giuseppe Pinto, Carmine Varrassi, Giustino Opioid-Induced Constipation in Real-World Practice: A Physician Survey, 1 Year Later |
title | Opioid-Induced Constipation in Real-World Practice: A Physician Survey, 1 Year Later |
title_full | Opioid-Induced Constipation in Real-World Practice: A Physician Survey, 1 Year Later |
title_fullStr | Opioid-Induced Constipation in Real-World Practice: A Physician Survey, 1 Year Later |
title_full_unstemmed | Opioid-Induced Constipation in Real-World Practice: A Physician Survey, 1 Year Later |
title_short | Opioid-Induced Constipation in Real-World Practice: A Physician Survey, 1 Year Later |
title_sort | opioid-induced constipation in real-world practice: a physician survey, 1 year later |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098716/ https://www.ncbi.nlm.nih.gov/pubmed/35122615 http://dx.doi.org/10.1007/s40122-022-00354-4 |
work_keys_str_mv | AT alvarodomenico opioidinducedconstipationinrealworldpracticeaphysiciansurvey1yearlater AT coluzziflaminia opioidinducedconstipationinrealworldpracticeaphysiciansurvey1yearlater AT gianniwalter opioidinducedconstipationinrealworldpracticeaphysiciansurvey1yearlater AT lugobonifabio opioidinducedconstipationinrealworldpracticeaphysiciansurvey1yearlater AT marinangelifranco opioidinducedconstipationinrealworldpracticeaphysiciansurvey1yearlater AT massazzagiuseppe opioidinducedconstipationinrealworldpracticeaphysiciansurvey1yearlater AT pintocarmine opioidinducedconstipationinrealworldpracticeaphysiciansurvey1yearlater AT varrassigiustino opioidinducedconstipationinrealworldpracticeaphysiciansurvey1yearlater |